[Skip to Navigation]
Article
December 1964

Patients With Mitral Stenosis and Systemic Emboli: Hemodynamic and Clinical Observations

Author Affiliations

BOSTON

From the Thorndike Memorial Laboratory and the second and fourth (Harvard) medical services, Boston City Hospital, and the Department of Medicine, Harvard Medical School.; Formerly Research Fellow, Thorndike Memorial Laboratory, Boston City Hospital, and Research Fellow in Medicine, Harvard Medical School, present address: Toronto General Hospital, Toronto, Canada (Dr. Casella); Assistant Physician, Thorndike Memorial Laboratory, Boston City Hospital, and Associate Clinical Professor of Medicine, Harvard Medical School (Dr. Abelmann); Visiting Physician, Boston City Hospital, and Clinical Professor of Medicine, Harvard Medical School (Dr. Ellis).

Arch Intern Med. 1964;114(6):773-781. doi:10.1001/archinte.1964.03860120085008
Abstract

Introduction  In 1933, Weiss and Davis analyzed 164 cases of fatal rheumatic heart disease that came to postmortem examination at the Boston City Hospital and reported that death was caused by systemic emboli in 25 instances or 15%.1 In a clinicopathologic study of 101 cases of mitral stenosis examined at the Boston City Hospital between 1945 and 1949, peripheral infarcts were found in 49 cases; ten of these were associated with subacute bacterial endocarditis.2 In 33 patients of this series systemic emboli were the cause of death.In the intervening years, the clinical course of rheumatic mitral stenosis has been markedly altered by advances in the surgical treatment of obstruction at the mitral valve, in the medical treatment of congestive heart failure and of subacute bacterial endocarditis, and in the chemotherapeutic prevention of recurrences of active rheumatic fever. On the other hand, there is no evidence that

Add or change institution
×